Sustained release formulations
US7323169B2 · kind B2 · utility
12Cited by
11References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 25, 2005 |
| Grant date | Jan 29, 2008 |
| Priority date | — |
| Expiry date | Jun 4, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0019
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates broadly to the field of sustained release formulations. More specifically, the invention describes compositions and methods relating to formulating proteins and/or peptides with purified gallic acid esters. In one example, the gallic acid ester is PentaGalloylGlucose (PGG) and in anther example the gallic acid ester is epigallocatechin gallate (EGCG).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.